Skip to main content
Premium Trial:

Request an Annual Quote

Privacy Worries

The Guardian reports that only one in 10 people invited to take part in the UK's Biobank project are signing up due in part to privacy concerns. The goal of the project is to follow and collect medical data from a half a million Britons between the ages of 40 and 69 to study the influence of environment, genes, and lifestyle on disease risk. Anonymous data from the study will be entered into a database that approved researchers can access. A report from the Biobank ethics councils says that potential participants are worried that their information will be shared with companies.


The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.